Results 211 to 220 of about 95,889 (290)

Post‐COVID‐19 Maxillary Bony Sequestration: A Case Report on Mucormycosis Challenges

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT COVID‐19‐associated mucormycosis (CAM) is a severe opportunistic infection, typically affecting immunocompromised patients. Maxillary bony sequestration as a delayed complication in immunocompetent individuals is rare, highlighting diagnostic and therapeutic challenges.
Saleh Mohebbi   +3 more
wiley   +1 more source

A Rare Case of Blastomycosis in a Psoriasis Patient Treated With Ustekinumab (Stelara)

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Psoriasis is a chronic inflammatory skin condition mediated by T‐helper 1 (Th1) and T‐helper 17 (Th17) cytokines, including interleukin (IL)‐12, IL‐23, IL‐17, and tumor necrosis factor alpha (TNF‐α). Ustekinumab, a human monoclonal antibody against the p40 subunit of IL‐12/23, has revolutionized treatment of moderate to severe psoriasis but ...
Fatima Ghaffar   +6 more
wiley   +1 more source

Monitoring the Molecular Conformation of Individual Amphotericin B Molecules in an Aggregated State by Raman Optical Activity. [PDF]

open access: yesAnal Chem
Pajor K   +10 more
europepmc   +1 more source

Complete Resolution of Cutaneous Leishmaniasis With a Novel Topical Combination Therapy: A Case Series

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Cutaneous leishmaniasis (CL) remains a therapeutic challenge in endemic regions, with 600,000–1 million new cases annually facing limited treatment options. We present a case series evaluating an innovative topical combination therapy for acute‐phase CL in Shiraz, Iran.
Hoda Haghshenas   +3 more
wiley   +1 more source

Recalcitrant Fungal Prosthetic Joint Infection of the Knee Cleared Using Voriconazole via Intra‐Articular Catheters

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Prosthetic joint infection (PJI) is a high‐cost and high‐morbidity complication of total joint arthroplasty accounting for about 1%–2% of all joint replacements. Rarely, a fungal pathogen may cause coinfection or superinfection and complicate treatment.
Matthew Hnatow   +2 more
wiley   +1 more source

Amphotericin B Resistant Aspergillus spp.: Report of Two Cases. [PDF]

open access: yesInfect Dis Clin Microbiol
Kaya A   +8 more
europepmc   +1 more source

Immunomodulating properties of the N-(1----) derivative of amphotericin B in mice

open access: bronze, 1989
Nelly Henry‐Toulmé   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy